1. Home
  2. FNWD vs CRBP Comparison

FNWD vs CRBP Comparison

Compare FNWD & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

HOLD

Current Price

$36.41

Market Cap

155.0M

Sector

Finance

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.16

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
CRBP
Founded
1994
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.0M
134.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
FNWD
CRBP
Price
$36.41
$8.16
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$34.00
$46.17
AVG Volume (30 Days)
4.2K
157.7K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
1.31%
N/A
EPS Growth
44.90
64.31
EPS
1.42
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
$100.00
P/E Ratio
$25.70
N/A
Revenue Growth
N/A
97.62
52 Week Low
$26.46
$4.64
52 Week High
$39.99
$20.56

Technical Indicators

Market Signals
Indicator
FNWD
CRBP
Relative Strength Index (RSI) 51.99 51.67
Support Level $36.37 $7.77
Resistance Level $38.75 $8.50
Average True Range (ATR) 1.02 0.49
MACD -0.04 0.09
Stochastic Oscillator 64.55 65.13

Price Performance

Historical Comparison
FNWD
CRBP

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: